Semax is a synthetic ACTH(4-7) analog investigated for acute ischemic stroke and neurological rehabilitation. Research demonstrates that it upregulates BDN
Read more Semax in Ischemic Stroke Research: Mechanisms and Clinical Trials
ARA-290 (cibinetide) is an investigational peptide evaluated in Phase 2 clinical trials for small fiber neuropathy. This review examines published human tr
Read more ARA-290 in Small Fiber Neuropathy: What Clinical Trials Show
BPC-157 has gained significant attention for tissue repair, but what does the toxicological data show? This scientific review examines preclinical toxicolo
Read more BPC-157 Safety, Toxicology, and Regulatory Status: A Scientific Review
A scientific review of semaglutide research across cardiovascular, hepatic, and neural organ systems, detailing clinical trial data, biological mechanisms,
Read more Semaglutide Research: Evidence Across Neural, Cardiovascular, and Hepatic Models
Epitalon shows intriguing telomerase and longevity effects in laboratory and animal models, but human evidence remains preliminary. This review examines pr
Sermorelin is a synthetic 29-amino-acid peptide corresponding to the functional fragment of endogenous growth hormone-releasing hormone. This review outlin
Read more Sermorelin: FDA History, Endocrine Mechanisms, and Current Research
The Wolverine peptide stack combines BPC-157 and TB-500, two research compounds investigated for soft tissue repair. While rodent models demonstrate angiog
Read more The Wolverine Peptide Stack: Preclinical Evidence, Safety Gaps, and Research Reality
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist that acts within the central nervous system. By activating hypothalamic MC3R and MC4R p
Read more PT-141: Central Nervous System Mechanism and Melanocortin Signaling
An evidence-based scientific review of Thymosin Alpha-1 (thymalfasin), examining its molecular targets, Toll-like receptor signaling pathways, dual immunom
Read more Thymosin Alpha-1 Research: Mechanism, Evidence, and Clinical Status
An evidence-based scientific review of survodutide (BI 456906), exploring its dual GLP-1 and glucagon receptor agonism, Phase 2 trial results in MASH and o
Read more Survodutide: Mechanism of Action and Clinical Trial Evidence